Impact of COVID-19 on the U.S. Pharmacy Benefits Management Market, 2020-2025

DUBLIN, June 5, 2020 /PRNewswire/ -- The "Pharmacy Benefit Management Market in US - Industry Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

In-depth analysis and data-driven insights on the impact of COVID-19 included in this U.S. pharmacy benefit management market report.

• What is the U.S. Pharmacy Benefit Management Market Size in 2020?
• What is the growth rate (CAGR) of the U.S. PBM Market during 2020-2025
• Which are the leading segment of the U.S. PBM Market?
• Impact of COVID-19 on the Pharmacy Benefits Management Market in the U.S.?

The U.S. pharmacy benefit management market is expected to grow at a CAGR of over 7% during the period 2019-2025.

The U.S. healthcare landscape is complex. It is riddled with wastage, drug abuse, and fraud due to a whirlwind of causative factors, putting patients at risk and creating a dilemma for insurers. It translates to high out-of-pocket costs, increased incidences of inappropriate spending, higher premiums, reduced benefits or coverage for consumers, increases cost of doling out insurance benefits for governments, and private employers. With a high number of consumers being enrolled in high-deductible health plans, there is a need for coordinated and broad effort to fix loopholes.

Pharmacy benefit managers are well-positioned as patients advocate to work with players across the board, with every member in the healthcare industry. PBM pharmacists can witness a complete picture of the member's medication background. This has enabled them to drive awareness among pharmacists and doctors/physicians to identify challenges and enable the delivery of better treatment through better communication and care coordination across the healthcare continuum for each patient.

Market Dynamics

Opportunities & Trends

• Foray into Digital Health Solutions
• Shift to Value / Outcomes-Based Contracts
• Move Away from a Standalone Mentality
• Increased Engagement in High-Touch Care Management

Growth Enablers

• Gaps in Information and Care in the Healthcare Industry
• Growth in FDA Approvals for Orphan and Specialty Drugs
• Prevalence of Fraud, Waste, and Abuse in Healthcare
• Shift Towards Individualized Medicines

Restraints

• PBMs Maligned and Scrutinized for Pricing
• Declining Growth from Generics
• Legal Uncertainty & Impending Limitations on PBM Tools
• Significant Delays Cause Dissatisfaction

This research report includes a detailed segmentation by services, health plan, and business model.

Specialty pharmacy - a segment of the U.S. Pharmacy Benefit Management market, which is a collaborative, clinical, integrated environment, is recording significant growth in the US pharmacy benefit management market. The segment has cemented its place in the continuum of healthcare, backed by a healthy level of activity in payer access and data systems. As specialty drugs have outpaced all the other elements of healthcare costs, the segment is keeping payers' on the edge of their seats. Since specialty pharmacies and mail-order pharmacies operate on a similar model in terms of medication deliveries. There are apprehensions about conflicts of interest and about how PBMs tag specific drugs as specialty.

Drugs, which treat auto-immune conditions, are growing at the fastest rate in commercial health plans. With emerging therapies that come at a high cost, the per-member, per-month spending on these therapies has witnessed an upward trend over the past couple of years. The increased focus of commercial health plan providers is on monitoring use and keeping the cost of drugs in check. This has led to an increased focus on utilization monitoring and formulary design, driving better prospects for the segment.

Commercial plan sponsors are also looking to increase resources to help employees access behavioral and mental health services as they struggle with maintaining the usefulness of prescription management services. The enrollment in Medicare Part D plans has grown 2X times over the last 15 years. Seeing as Medicare is designed to absorb risk, providing for individuals with complex, expensive medical needs, along with relatively healthy individuals, these plans rely heavily on PBMs.

The Pharmacy benefit management market in US is well backed, fortifying future growth by ramping up the capital investment in data analytics capabilities and technology R&D. As employers continue to concentrate on whole-person health, providing a total benefits solution, which is vital to draw and keep talent, this segment is expected to grow.

As insurance companies launch new products for gene therapies, they are considering offering therapy management techniques. The key players in the market are keeping a tab on the gene therapy pipeline and tracing patient outcomes, which are being used as a starting point for value-based arrangements that the company is on with pharma manufacturers. This is drawing attention, particularly from employers, creating favorability for players with these business models. The pharmacy benefit management market in US is highly fragmented.

Market Segmentation

By Health Plans

• Commercial Health Plan
• Self-insured Employer Plan
• Medical Part D Plans
• Managed Medicaid Programs
• Other

By Services

• Specialty Pharmacy Services
• Retail Pharmacy Services
• Mail-order Pharmacy Services
• Benefit Plan Design & Administration
• Formulary Management
• Clinical Programs & Services
• Others

By Business Model

• Insurance Companies & Retail Pharmacies
• Pure Play PBMs

Insights by Vendors

The Pharmacy Benefit Management market in US share has changed considerably in the last couple of years, where acquisitions led the market to where it is today, occupied mostly by a couple of giants. As a result, the PBM industry is highly concentrated with Caremark, Express Scripts, and OptumRX, accounting for more than 70% of claims volume. They have been the shapeshifters in the PBM space. However, that again is changing as insurers have been building their presence in the market by dissolving existent relationships with PBMs and acquiring or launching their own.

Key Vendors

• CVS Caremark
• Express Scripts
• OptumRx
• Humana Pharmacy Solutions

Other Prominent Vendors

• Abarca Health
• Anthem
• AscellaHealth
• BeneCard PBF
• Centene
• Citizens Rx
• EnvisionRxOptions
• Excelera
• Magellan Rx Management
• MedalistRx
• MedImpact
• Prime Therapeutics
• MaxorPlus
• Navitus Health Solutions
• Perform Rx
• RxAdvance
• WellDyneRx

For more information about this report visit https://www.researchandmarkets.com/r/nsnzsl

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com